Robust Chemoenzymatic Synthesis of Keratinimicin Aglycone Analogues Facilitated by the Structure and Selectivity of OxyB
- 5 July 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 18 (7) , 1473-1479
Abstract
The emergence of multidrug-resistant pathogens poses a threat to public health and requires new antimicrobial agents. As the archetypal glycopeptide antibiotic (GPA) used against drug-resistant Gram-positive pathogens, vancomycin provides a promising starting point. Peripheral alterations to the vancomycin scaffold have enabled the development of new GPAs. However, modifying the core remains challenging due to the size and complexity of this compound family. The recent successful chemoenzymatic synthesis of vancomycin suggests that such an approach can be broadly applied. Herein, we describe the expansion of chemoenzymatic strategies to encompass type II GPAs bearing all aromatic amino acids through the production of the aglycone analogue of keratinimicin A, a GPA that is 5-fold more potent than vancomycin against Clostridioides difficile. In the course of these studies, we found that the cytochrome P450 enzyme OxyBker boasts both broad substrate tolerance and remarkable selectivity in the formation of the first aryl ether cross-link on the linear peptide precursors. The X-ray crystal structure of OxyBker, determined to 2.8 Å, points to structural features that may contribute to these properties. Our results set the stage for using OxyBker broadly as a biocatalyst toward the chemoenzymatic synthesis of diverse GPA analogues.Keywords
All Related Versions
Funding Information
- Division of Chemistry (1937971)
- Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung (P2EZP2_187995)
- National Institute of General Medical Sciences (R01 GM129496, R35 GM147557)
This publication has 39 references indexed in Scilit:
- Silver(I)-Promoted Conversion of Thioamides to Amidines: Divergent Synthesis of a Key Series of Vancomycin Aglycon Residue 4 Amidines That Clarify Binding Behavior to Model LigandsJournal of the American Chemical Society, 2012
- Total Synthesis of [Ψ[C(═S)NH]Tpg4]Vancomycin Aglycon, [Ψ[C(═NH)NH]Tpg4]Vancomycin Aglycon, and Related Key Compounds: Reengineering Vancomycin for Dual d-Ala-d-Ala and d-Ala-d-Lac BindingJournal of the American Chemical Society, 2011
- A Redesigned Vancomycin Engineered for Dual d-Ala-d-Ala and d-Ala-d-Lac Binding Exhibits Potent Antimicrobial Activity Against Vancomycin-Resistant BacteriaJournal of the American Chemical Society, 2011
- Large-scale evaluation of protein reductive methylation for improving protein crystallizationNature Methods, 2008
- New insights into the first oxidative phenol coupling reaction during vancomycin biosynthesisBioorganic & Medicinal Chemistry Letters, 2008
- Oxidative Phenol Coupling Reactions Catalyzed by OxyB: A Cytochrome P450 from the Vancomycin Producing Organism. Implications for Vancomycin BiosynthesisJournal of the American Chemical Society, 2007
- Crystal Structure of OxyB, a Cytochrome P450 Implicated in an Oxidative Phenol Coupling Reaction during Vancomycin BiosynthesisJournal of Biological Chemistry, 2002
- Total Synthesis of the Vancomycin AglyconJournal of the American Chemical Society, 1999
- Crystal structure of vancomycinStructure, 1996
- Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the storyChemistry & Biology, 1996